CANF
Can-Fite BioPharma
CANF
CANF
7 hedge funds and large institutions have $854K invested in Can-Fite BioPharma in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
Holders
7
Holders Change
-5
Holders Change %
-41.67%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
|
$763K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$11K |
Top Sellers
| 1 |
ES
1
Equitec Specialists
Chicago,
Illinois
|
$0 |
| 2 |
2
Renaissance Technologies
New York
|
$0 |
| 3 |
VKH
3
Virtu KCG Holdings
New York
|
$48K |
| 4 |
4
Goldman Sachs
New York
|
$0 |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
| $763K | 348,500 | +329,600 | +1,744% |
|
|
VKH
2
Virtu KCG Holdings
New York
| $48K | 22,042 | -28,373 | -56% |
|
|
MC
3
Menta Capital
San Francisco,
California
| $27K | 12,200 | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $11K | 5,194 | +2,933 | +130% |
|
|
MFS
5
MSI Financial Services
Springfield,
Massachusetts
| $4K | 2,000 | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $1K | 458 | -238 | -34% |
|
|
ES
7
Equitec Specialists
Chicago,
Illinois
| – | – | -118,850 | Closed |
|
|
8
Renaissance Technologies
New York
| – | – | -85,000 | Closed |
|
|
9
Citadel Advisors
Miami,
Florida
| – | – | -10,485 | Closed |
|
|
10
Goldman Sachs
New York
| – | – | -10,421 | Closed |
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -7,476 | Closed |
|
12
Citigroup
New York
| $0 | 17 | -470 | -97% |
|